Su-Jau Yang, PhD

Articles by Su-Jau Yang, PhD

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

ByLisa M. Nyberg, MD, MPH,Ankita Kaushik, PhD,Nathaniel Smith, PhD,Fadoua El Moustaid, PhD,Anders H. Nyberg, MD, PhD,Su-Jau Yang, PhD,Kevin M. Chiang, PharmD, MBA,Alon Yehoshua, PharmD, MS

October 20th 2023

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.

Latest Updated Articles

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California
October 20th 2023